IDEX CORP (IEX)

US45167R1041 - Common Stock

227.45  +4.34 (+1.95%)

After market: 227.45 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to IEX. IEX was compared to 131 industry peers in the Machinery industry. IEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IEX is quite expensive at the moment. It does show a decent growth rate. These ratings would make IEX suitable for quality investing!



7

1. Profitability

1.1 Basic Checks

In the past year IEX was profitable.
In the past year IEX had a positive cash flow from operations.
IEX had positive earnings in each of the past 5 years.
In the past 5 years IEX always reported a positive cash flow from operatings.

1.2 Ratios

IEX has a Return On Assets of 7.04%. This is in the better half of the industry: IEX outperforms 68.50% of its industry peers.
Looking at the Return On Equity, with a value of 12.84%, IEX is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 8.53%, IEX is in the better half of the industry, outperforming 62.99% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for IEX is in line with the industry average of 11.01%.
Industry RankSector Rank
ROA 7.04%
ROE 12.84%
ROIC 8.53%
ROA(3y)9.98%
ROA(5y)9.93%
ROE(3y)17.39%
ROE(5y)17.17%
ROIC(3y)11.6%
ROIC(5y)11.75%

1.3 Margins

IEX's Profit Margin of 15.35% is amongst the best of the industry. IEX outperforms 91.34% of its industry peers.
IEX's Profit Margin has improved in the last couple of years.
IEX has a Operating Margin of 21.82%. This is amongst the best in the industry. IEX outperforms 91.34% of its industry peers.
IEX's Operating Margin has been stable in the last couple of years.
IEX has a better Gross Margin (44.29%) than 85.83% of its industry peers.
IEX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.82%
PM (TTM) 15.35%
GM 44.29%
OM growth 3Y0.42%
OM growth 5Y-0.41%
PM growth 3Y4.26%
PM growth 5Y1.95%
GM growth 3Y0.38%
GM growth 5Y-0.36%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IEX is still creating some value.
The number of shares outstanding for IEX remains at a similar level compared to 1 year ago.
The number of shares outstanding for IEX has been reduced compared to 5 years ago.
The debt/assets ratio for IEX has been reduced compared to a year ago.

2.2 Solvency

IEX has an Altman-Z score of 5.04. This indicates that IEX is financially healthy and has little risk of bankruptcy at the moment.
IEX's Altman-Z score of 5.04 is fine compared to the rest of the industry. IEX outperforms 75.59% of its industry peers.
IEX has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as IEX would need 3.32 years to pay back of all of its debts.
IEX has a Debt to FCF ratio of 3.32. This is in the better half of the industry: IEX outperforms 64.57% of its industry peers.
A Debt/Equity ratio of 0.54 indicates that IEX is somewhat dependend on debt financing.
IEX has a Debt to Equity ratio (0.54) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 3.32
Altman-Z 5.04
ROIC/WACC0.95
WACC8.99%

2.3 Liquidity

IEX has a Current Ratio of 2.97. This indicates that IEX is financially healthy and has no problem in meeting its short term obligations.
IEX's Current ratio of 2.97 is fine compared to the rest of the industry. IEX outperforms 75.59% of its industry peers.
A Quick Ratio of 2.11 indicates that IEX has no problem at all paying its short term obligations.
The Quick ratio of IEX (2.11) is better than 77.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.11

5

3. Growth

3.1 Past

The earnings per share for IEX have decreased by -8.69% in the last year.
IEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.73% yearly.
The Revenue has decreased by -3.06% in the past year.
IEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.68% yearly.
EPS 1Y (TTM)-8.69%
EPS 3Y16.49%
EPS 5Y8.73%
EPS Q2Q%-10.38%
Revenue 1Y (TTM)-3.06%
Revenue growth 3Y11.66%
Revenue growth 5Y5.68%
Sales Q2Q%0.6%

3.2 Future

The Earnings Per Share is expected to grow by 11.43% on average over the next years. This is quite good.
IEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.83% yearly.
EPS Next Y-3.21%
EPS Next 2Y2.33%
EPS Next 3Y3.98%
EPS Next 5Y11.43%
Revenue Next Year0.67%
Revenue Next 2Y4.18%
Revenue Next 3Y5.18%
Revenue Next 5Y9.83%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.65, the valuation of IEX can be described as expensive.
IEX's Price/Earnings ratio is a bit more expensive when compared to the industry. IEX is more expensive than 62.20% of the companies in the same industry.
IEX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.96, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 26.43 indicates a quite expensive valuation of IEX.
The rest of the industry has a similar Price/Forward Earnings ratio as IEX.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, IEX is valued at the same level.
Industry RankSector Rank
PE 29.65
Fwd PE 26.43

4.2 Price Multiples

63.78% of the companies in the same industry are cheaper than IEX, based on the Enterprise Value to EBITDA ratio.
IEX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.54
EV/EBITDA 21.28

4.3 Compensation for Growth

The decent profitability rating of IEX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.4
EPS Next 2Y2.33%
EPS Next 3Y3.98%

6

5. Dividend

5.1 Amount

IEX has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.54, IEX pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.20, IEX pays less dividend than the S&P500 average, which is at 2.23.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

The dividend of IEX is nicely growing with an annual growth rate of 8.58%!
IEX has paid a dividend for at least 10 years, which is a reliable track record.
IEX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.58%
Div Incr Years14
Div Non Decr Years28

5.3 Sustainability

41.07% of the earnings are spent on dividend by IEX. This is a bit on the high side, but may be sustainable.
The dividend of IEX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.07%
EPS Next 2Y2.33%
EPS Next 3Y3.98%

IDEX CORP

NYSE:IEX (11/21/2024, 8:04:00 PM)

After market: 227.45 0 (0%)

227.45

+4.34 (+1.95%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.22B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 29.65
Fwd PE 26.43
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)3.4
Profitability
Industry RankSector Rank
ROA 7.04%
ROE 12.84%
ROCE
ROIC
ROICexc
ROICexgc
OM 21.82%
PM (TTM) 15.35%
GM 44.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.97
Quick Ratio 2.11
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-8.69%
EPS 3Y16.49%
EPS 5Y
EPS Q2Q%
EPS Next Y-3.21%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.06%
Revenue growth 3Y11.66%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y